Medical treatment improves social behavior in a primate endometriosis model (Callithrix jacchus)

Journal of Medical Primatology

Volumn 42, Issue 3, 2013, Pages 112-119

  Arnold, C ^a   Einspanier, A ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

17 HSD1 therapy; Behavioral tests; Common marmoset; Endometriosis; Refinement; Social behavior

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR; CALLITHRIX; COGNITION; CONTROLLED STUDY; DISEASE MODEL; ENDOMETRIOSIS; FEMALE; GROOMING; MALE; MOTOR PERFORMANCE; NONHUMAN; PRIORITY JOURNAL; SOCIAL BEHAVIOR;

17-HYDROXYSTEROID DEHYDROGENASES; ANIMALS; CALLITHRIX; COGNITION; DISEASE MODELS, ANIMAL; ENDOMETRIOSIS; FEMALE; GROOMING; MOTOR ACTIVITY; PAIN; SOCIAL BEHAVIOR; VIDEOTAPE RECORDING;

ANIMALIA; CALLITHRIX JACCHUS; PRIMATES;

EID: 84877642158     PISSN: 00472565     EISSN: 16000684     Source Type: Journal    
DOI: 10.1111/jmp.12042     Document Type: Article

References (40)

1. Aidoo-Gyamfi K, Cartledge T, Shah K, Ahmed S: Estrone sulfatase and its inhibitors. Anticancer Agents Med Chem 2009; 9:599-612.
2. Amsterdam LL, Gentry W, Jobanputra S, Wolf M, Rubin SD, Bulun SE: Anastrazole and oral contraceptives: a novel treatment for endometriosis. Fertil Steril 2005; 84:300-4.
3. Arnold C, Lamp J, Lamp O, Einspanier A: Behavioral tests as indicator for pain and distress in a primate endometriosis model. J Med Primatol 2011; 40:317-26.
4. Barclay RJ, Herbert WJ, Poole TB: The Disturbance Index: a behavioural method of assessing the severity of common laboratory procedures on rodents. UFAW Animal Welfare Research Report 1988; 2:2-36.
5. Becker CM, Bartley J, Mechsner S, Ebert AD: Angiogenese und Endometriose. Zentralbl Gynakol 2004; 126:252-8.
6. Bulun SE, Yang S, Fang Z, Gurates B, Tamura M, Sebastian S: Estrogen production and metabolism in endometriosis. Ann N Y Acad Sci 2002; 955:75-85.
7. Chalmers N: Social behavior in primates. Baltimore: University Park Press, 1980.
8. Chen Y, Chen C, Shi S, Han J, Wang J, Hu J, Liu Y, Cai Z, Yu C: Endometriotic implants regress in rat models treated with puerarin by decreasing estradiol level. Reprod Sci 2011; 18:886-91.
9. D'Hooghe TM, Cuneo S, Nugent N, Chai D, Deer F, Mwenda J: Recombinant human TNF binding protein-1 (r-hTBP-1) inhibits the development of endometriosis in baboons: a prospective, randomized, placebo- and drug-controlled study. Fertil Steril 2001; 76:O2.
10. Dassen H, Punyadeera C, Kamps R, Delvoux B, van Langendonckt A, Donnez J, Husen B, Thole H, Dunselman G, Groothuis P: Estrogen metabolizing enzymes in endometrium and endometriosis. Hum Reprod 2007; 22:3148-58.
11. Delvoux B, Groothuis P, D'Hooghe T, Kyama C, Dunselman G, Romano A: Increased production of 17beta-estradiol in endometriosis lesions is the result of impaired metabolism. J Clin Endocrinol Metab 2009; 94:876-83.
12. Ebert AD, Bartley J, David M, Schweppe KW: Aromatasehemmer - theoretisches Konzept und bisherige Erfahungen in der Endometriosetherapie. Zentralbl Gynakol 2003; 8:247-51.
13. Einspanier A, Lieder K, Bruns A, Husen B, Thole H, Simon C: Induction of endometriosis in the marmoset monkey (Callithrix jacchus). Mol Hum Reprod 2006; 12:291-9.
14. Flecknell PA: Recognition and alleviation of pain in animals. In: Advances in animal welfare science. Fox, Mickley (eds). Dordrecht: Martinus Nijhoff Publishers, 1986; 61-77.
15. Goosen C: Social grooming in primates. In: Comparative Primate Biology. Mitchell, Erwin (eds). New York: Alan Liss, 1987; 107-31.
16. Halban J: Hysteradenosis metastatica, die lymphogene Genese der sog. Adenofibromatosis heterotopica. Wien Klin Wochenschr 1924; 37: 1205-6.
17. Hompes PG, Mijatovic V: Endometriosis: the way forward. Gynecol Endocrinol 2007; 23:5-12.
18. Honess PE, Marin C, Brown AP, Wolfensohn SE: Assessment of stress in non-human primates: application of the neutrophil activation test. Anim Welfare 2005; 14:291-5.
19. Joint Working Group on Refinement: Refinements in husbandry, care and common procedures for non-human primates: Ninth report of the BVAAWF/FRAME/RSPCA/UFAW Joint Working Group on Refinement (M Jennings & MJ Prescott, eds). Lab Anim 2009; 43:S1-47.
20. Kennedy S, Bergqvist A, Chapron C, D'Hooghe T, Dunselman G, Greb R, Hummelshoj L, Prentice A, Saridogan E: ESHRE guideline for the diagnosis and treatment of endometriosis. Hum Reprod 2005; 20:2698-704.
21. Kettel LM, Murphy AA, Mortola JF, Liu JH, Ulmann A, Yen SS: Endocrine responses to long-term administration of the antiprogesterone RU486 in patients with pelvic endometriosis. Fertil Steril 1991; 56:402-7.
22. Kitawaki J, Kado N, Ishihara H, Koshiba H, Kitaoka Y, Honjo H: Endometriosis: the pathophysiology as an estrogen-dependent disease. J Steroid Biochem Mol Biol 2002; 5:149-55.
23. Liu HY, Liao SX, Zhou SL, Zhang DY, Liu HN, Zhao XL, Dong L, Wu D, Wang T, Chu Y, Hou QF, Guo QN, Li T, Wang L, He M, Zhao HR, Yang K, Zhang CY, Huang FF, Yang YL: Experimental endometriosis reduction in rats treated with pioglitazone. Afr J Microbiol Res 2012; 6:2580-5.
24. Low WY, Edelmann RJ: Psychosocial-Aspects of Endometriosis - A Review. J Psychosom Obstet Gynecol 1991; 12:3-12.
25. Marchais-Oberwinkler S, Wetzel M, Ziegler E, Kruchten P, Werth R, Henn C, Hartmann RW, Frotscher M: New drug-like hydroxyphenylnaphthol steroidomimetics as potent and selective 17beta-hydroxysteroid dehydrogenase type 1 inhibitors for the treatment of estrogen-dependent diseases. J Med Chem 2011; 54:534-47.
26. Messinger J, Hirvela L, Husen B, Kangas L, Koskimies P, Pentikainen O, Saarenketo P, Thole H: New inhibitors of 17beta-hydroxysteroid dehydrogenase type 1. Mol Cell Endocrinol 2006; 2:192-8.
27. Meyer R: Über den Stand der Frage der Adenomyositis und Adenomyome im allgemeinen und insbesondere über Adenomyositis seroepithelialis und Adenomyometritis sarcomatosa. Zentralbl Gynakol 1919; 36:745-50.
28. Moline ML, Broch L, Zak R, Gross V: Sleep in women across the life cycle from adulthood through menopause. Sleep Med Rev 2003; 7:155-77.
29. Moller G, Husen B, Kowalik D, Hirvela L, Plewczynski D, Rychlewski L, Messinger J, Thole H, Adamski J: Species used for drug testing reveal different inhibition susceptibility for 17beta-hydroxysteroid dehydrogenase type 1. PLoS ONE 2010; 5:e10969.
30. Morton DB, Griffiths PHM: Guidelines on the Recognition of Pain, Distress and Discomfort in Experimental-Animals and An Hypothesis for Assessment. Vet Rec 1985; 116:431-6.
31. Olive DL, Schwartz LB: Endometriosis. N Engl J Med 1993; 328:1759-69.
32. Oster A, Hinsberger S, Werth R, Marchais-Oberwinkler S, Frotscher M, Hartmann RW: Bicyclic substituted hydroxyphenylmethanones as novel inhibitors of 17beta-hydroxysteroid dehydrogenase type 1 (17beta-HSD1) for the treatment of estrogen-dependent diseases. J Med Chem 2010; 53:8176-86.
33. Poirier D: Inhibitors of 17 beta-hydroxysteroid dehydrogenases. Curr Med Chem 2003; 10:453-77.
34. Poole TB: Normal and abnormal behavior in captive primates. Primate Rep 1988; 22:3-11.
35. Sambraus HH: Grundbegriffe im Tierschutz. In: Das Buch vom Tierschutz. Sambraus HH, Steiger A (eds). Stuttgart: Ferdinand Enke Verlag, 1997; 30-9.
36. Sampson JA: Peritoneal endometriosis due to menstrual dissemination of endometrial tissue into the peritoneal cavity. Am J Obstet Gynecol 1927; 14:422-69.
37. Smuc T, Pucelj MR, Sinkovec J, Husen B, Thole H, Lanisnik RT: Expression analysis of the genes involved in estradiol and progesterone action in human ovarian endometriosis. Gynecol Endocrinol 2007; 23:105-11.
38. Verkauf BS: Incidence, symptoms, and signs of endometriosis in fertile and infertile women. J Fla Med Assoc 1987; 74:671-5.
39. Waller KG, Shaw RW: Gonadotropin-releasing hormone analogues for the treatment of endometriosis: long-term follow-up. Fertil Steril 1993; 59:511-15.
40. Zeitoun KM, Bulun SE: Aromatase: a key molecule in the pathophysiology of endometriosis and a therapeutic target. Fertil Steril 1999; 72:961-9.